MediPharm Labs

Net Revenue: $9.8M in Q3 2024, a 15% increase as compared to Q3 2023. International medical cannabis revenue grew 37% versusQ3 2023 and represented 36% of revenues in the quarter. …

15%
OFF

MediPharm Labs

2 weeks from now

Net Revenue: $9.8M in Q3 2024, a 15% increase as compared to Q3 2023. International medical cannabis revenue grew 37% versusQ3 2023 and represented 36% of revenues in the quarter. …

medipharmlabs.com

37%
OFF

CBD Pharma Co. MediPharm: 37% Increase In Q3 International …

2 weeks from now

12 hours ago · MediPharm Labs reports 15% YoY revenue growth in Q3 2024, with international sales up 37% and gross margin at 32%. MediPharm is now free of any material debt fter fully …

benzinga.com

15%
OFF

MediPharm Labs Q3 Revenue Jumps 15% To $9.8M, Achieves Debt …

2 weeks from now

14 hours ago · MediPharm Labs reported Q3 2024 financial results showing significant improvements. Net revenue reached $9.8M, a 15% increase from Q3 2023, with international …

stocktitan.net

15%
OFF

MediPharm Labs Reports Third Quarter Results - Morningstar

2 weeks from now

1 day ago · Net Revenue: $9.8M in Q3 2024, a 15% increase as compared to Q3 2023. International medical cannabis revenue grew 37% versus Q3 2023 and represented 36% of …

morningstar.com

15%
OFF

MediPharm Labs Brief: Net Revenue $9.8 Million In Q3 2024, A 15% ...

2 weeks from now

14 hours ago · MediPharm Labs Brief: Net Revenue $9.8 Million in Q3 2024, a 15% increase as compared to Q3 2023; Cites Strong Growth in International GMP Medical Markets 07:32am: …

marketscreener.com

37%
OFF

MediPharm Labs Reports Third Quarter Results

2 weeks from now

approximately $5.9M in Q3. Retrospectively, if VIVO were included in our Q3 2022 results, Opex in Q3 2023 is approximately 37% or $3.6M lower reflecting our combined cost reduction …

website-files.com

8%
OFF

MediPharm Labs Reports Gross Profit Improvement In Latest …

2 weeks from now

Aug 14, 2024 · Net Revenue: $10.3M in Q2 2024, an 8% increase as compared to Q2 2023, and a 6% increase as compared to Q1 2024, representing the highest net revenue in over three …

thedalesreport.com

6923%
OFF

Canadian CBD-Focused Pharma Co. Gets Green Light To Produce …

2 weeks from now

Feb 7, 2024 · Now read: MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report MEDIF Price Action MediPharm's shares traded 2.6923% …

benzinga.com

5%
OFF

MediPharm Labs Sees 16.5% QoQ Increase In International

2 weeks from now

Nov 15, 2021 · CBD-focused pharmaceutical company MediPharm Labs Corp. LABS MEDIF MLZ announced its financial results on Monday for the three and nine months ended Sept. 30.. …

benzinga.com

37%
OFF

MediPharm Labs Reports Third Quarter Results - PR Newswire

2 weeks from now

14 hours ago · International medical cannabis revenue grew 37% versus Q3 2023 and represented 36% of revenues in the quarter. Canadian medical and business to business …

prnewswire.com

15%
OFF

MediPharm Labs Reports 15% Revenue Growth And 37% Rise In …

2 weeks from now

10 hours ago · CBD-based pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its third quarter financial results Thursday for the …

newsminimalist.com

37%
OFF

CBD Pharma Co. MediPharm: 37% Increase In Q3 International …

2 weeks from now

CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth. Benzinga 11-14 22:37. CBD-based pharmaceutical ... Q3 Financial Highlights. Net …

laohu8.com

$3
OFF

CV Sciences Q3: Revenue Stable Amid New Launches, Financing

2 weeks from now

5 hours ago · CV Sciences, Inc. CVSI, a hemp-focused wellness company, announced stable revenue in its Q3 2024 financials on Thursday. The company generated $3.9 million in …

benzinga.com

37%
OFF

CBD Pharma Co. MediPharm: 37% Increase In Q3 International …

2 weeks from now

1 day ago · This article CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth originally appeared on Benzinga.com.Weiter z...

finanzen.ch

FAQs about MediPharm Labs Coupon?

What is medipharm labs doing in 2021?

2021 was a year of transition for MediPharm Labs and paved the strategic foundation for the future. The following highlights the Company’s focus areas on its path to profitability. MediPharm Labs continues to operate with a strong cash position and clean balance sheet. ...

When did medipharm acquire VIVO Cannabis?

In 2023, MediPharm acquired VIVO Cannabis Inc. which expanded MediPharm's reach to medical patients in Canada via Canna Farms medical ecommerce platform, and in Australia and Germany through Beacon Medical PTY and Beacon Medical GMBH. ...

What does medipharm labs stand for?

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three months ended September 30, 2023. ...

Which segment dominated the CBD market in 2023?

B2B segment dominated the market and accounted for the largest revenue share of 53.8% in 2023. This segment is anticipated to grow at the fastest CAGR over the forecast period, owing to a rise in the number of wholesalers offering CBD oil and the growing demand for CBD oil as a raw material. ...

Does medipharm labs have a good balance sheet?

MediPharm Labs continues to operate with a strong cash position and clean balance sheet. With the Company’s only debt agreement being a 2020 convertible debenture that holds a balance of less than $500K, down from an original balance of over $40M. ...

Who is medipharm labs?

In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment Licence from Health Canada, becoming the only company in to hold a domestic Good Manufacturing Licence for the extraction of natural cannabinoids. The Company carries out its operations in compliance with all applicable laws in the countries in which it operates. ...